Evidence map›Paper›PMID 40338305›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Noninvasive diagnosis and classification of kidney transplantation rejection by

Sulin Luo, Mimi Xu, Rongfang Shen, Meifang Wang, Qinyun Wu, Tianlu Zhang, Zhenpeng Jin, Pengpeng Yan, Luying Guo, Jingyi Zhou and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. First Experience with [Diagnostics (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sulin Luo *Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Mimi Xu *Department of Nuclear Medicine, PET Centre, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.
Rongfang ShenKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Meifang WangKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qinyun WuKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Tianlu ZhangKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhenpeng JinKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pengpeng YanKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Luying GuoKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jingyi ZhouKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qin ZhouKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huiping WangKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Kui ZhaoDepartment of Nuclear Medicine, PET Centre, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.
Xinhui SuDepartment of Nuclear Medicine, PET Centre, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China. suxinhui@zju.edu.cn.
Rending WangKidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. rd_wangjia@zju.edu.cn.ORCID 0000-0002-2063-8533

Funding

National Natural Science Foundation of China 82070766National Natural Science Foundation of China 82400886Natural Science Foundation of Zhejiang Province LQ23H050003Natural Science Foundation of Zhejiang Province LQ23H050004
6 · The paper itself

Abstract

purposeRejection, especially chronic rejection is a key factor influencing the prognosis of kidney transplantation patients. While

methodsIn this study, 24 kidney transplant recipients were prospectively enrolled and divided into a control cohort and a rejection cohort (KTR), which were further classified into acute rejection (AR), mixed rejection (MR), and chronic rejection (CR) subgroups. All patients underwent

resultsCompared with the control cohort, the KTR cohort showed significantly higher serum creatinine levels, lower estimated glomerular filtration rates, and lower hemoglobin levels. The SUVmax of

conclusion

Indexed as

Graft RejectionKidney TransplantationPositron Emission Tomography Computed TomographyAdultFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedFluorodeoxyglucose F18Acute kidney transplant rejectionChronic kidney transplant rejectionFAPI PET/CTFibroblast-activation-protein

Identifiers

PMID40338305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.